Press Release Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress 15 hours ago
Press Release Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025 Jul 16
Press Release Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists Jul 13